References
- Schmidt-ErfurthUChongVLoewensteinAGuidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA)Br J Ophthalmol20149891144116725136079
- BlochSBLarsenMMunchICIncidence of legal blindness from age-related macular degeneration in Denmark: year 2000 to 2010Am J Ophthalmol20121532209213.e222264944
- BelkinMKalter-LeiboviciOChetritASkaatATime trends in the incidence and causes of blindness in IsraelAm J Ophthalmol2013155240423312440
- MitchellPBresslerNDoanQVEstimated cases of blindness and visual impairment from neovascular age-related macular degeneration avoided in Australia by ranibizumab treatmentPLoS One201496e10107224979237
- BresslerNMDoanQVVarmaREstimated cases of legal blindness and visual impairment avoided using ranibizumab for choroidal neovascularization: non-Hispanic white population in the United States with age-related macular degenerationArch Ophthalmol2011129670971721670337
- RofaghaSBhisitkulRBBoyerDSSaddaSRZhangKSeven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP)Ophthalmology2013120112292229923642856
- HolzFGSchmitz-ValckenbergSFleckensteinMRecent developments in the treatment of age-related macular degenerationJ Clin Invest201412441430143824691477
- FerrisFL3rdFineSLHymanLAge-related macular degeneration and blindness due to neovascular maculopathyArch Ophthalmol198410211164016426208888
- GrossniklausHEGreenWRChoroidal neovascularizationAm J Ophthalmol2004137349650315013874
- FreundKBHoIVBarbazettoIAType 3 neovascularization: the expanded spectrum of retinal angiomatous proliferationRetina200828220121118301024
- SoubraneGCoscasGFrançaisCKoenigFOccult subretinal new vessels in age-related macular degeneration. Natural history and early laser treatmentOphthalmology19909756496572342811
- LafautBABartz-SchmidtKUVanden BroeckeCAisenbreySDe LaeyJJHeimannKClinicopathological correlation in exudative age related macular degeneration: histological differentiation between classic and occult choroidal neovascularisationBr J Ophthalmol200084323924310684831
- BalasubramanianSAKrishna KumarKBairdPNThe role of proteases and inflammatory molecules in triggering neovascular age-related macular degeneration: basic science to clinical relevanceTransl Res2014164317919224794954
- WongTYChakravarthyUKleinRThe natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysisOphthalmology2008115111612617675159
- SchmierJKCovertDWLauECPatterns and costs associated with progression of age-related macular degenerationAm J Ophthalmol20121544675681.e122835513
- CampaCHardingSPPearceIABeareNABriggsMCHeimannHIncidence of neovascularization in the fellow eye of patients with unilateral retinal angiomatous proliferationEye (Lond)201024101585158920539314
- LiuTYShahARDel PrioreLVProgression of lesion size in untreated eyes with exudative age-related macular degeneration: a meta-analysis using Lineweaver-Burk plotsJAMA Ophthalmol2013131333534023494038
- BlinderKJBradleySBresslerNMEffect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no 1Am J Ophthalmol2003136340741812967792
- BoyerDSAntoszykANAwhCCBhisitkulRBShapiroHAcharyaNRSubgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degenerationOphthalmology2007114224625217270674
- KaiserPKBrownDMZhangKRanibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR resultsAm J Ophthalmol2007144685085717949673
- YingGSHuangJMaguireMGBaseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degenerationOphthalmology2013120112212923047002
- Writing Committee for the UK Age-Related Macular Degeneration EMR Users GroupThe neovascular age-related macular degeneration database: multicenter study of 92 976 ranibizumab injections: report 1: visual acuityOphthalmology201412151092110124461586
- Zarranz-VenturaJLiewGJohnstonRLThe neovascular age-related macular degeneration database: report 2: incidence, management, and visual outcomes of second treated eyesOphthalmology2014121101966197524953791
- Oliver-FernandezABakalJSegalSShahGKDugarASharmaSProgression of visual loss and time between initial assessment and treatment of wet age-related macular degenerationCan J Ophthalmol200540331331915947801
- RauchRWeingesselBMacaSMVecsei-MarlovitsPVTime to first treatment: the significance of early treatment of exudative age-related macular degenerationRetina20123271260126422186738
- CananHSızmazSAltan-YaycıoğluRSarıtürkCYılmazGVisual outcome of intravitreal ranibizumab for exudative age-related macular degeneration: timing and prognosisClin Interv Aging2014914114524453484
- KandulaSLamkinJCAlbaneseTEdwardDPPatients’ knowledge and perspectives on wet age-related macular degeneration and its treatmentClin Ophthalmol2010437538120463907
- WooJHAu EongKGDon’t lose sight of age-related macular degeneration: the need for increased awareness in SingaporeSingapore Med J2008491185085319037547
- LauJTLeeVFanDLauMMichonJKnowledge about cataract, glaucoma, and age related macular degeneration in the Hong Kong Chinese populationBr J Ophthalmol200286101080108412234882
- MüllerAKeeffeJETaylorHRChanges in eye care utilization following an eye health promotion campaignClin Experiment Ophthalmol200735430530917539780
- CrosslandMRubinGThe Amsler chart: absence of evidence is not evidence of absenceBr J Ophthalmol200791339139317322466
- AmslerMEarliest symptoms of diseases of the maculaBr J Ophthalmol195337952153713081950
- MarmorMFA brief history of macular grids: from Thomas Reid to Edvard Munch and Marc AmslerSurv Ophthalmol200044434335310667441
- AugustinAJOffermannILutzJSchmidt-ErfurthUTornambePComparison of the original Amsler grid with the modified Amsler grid: result for patients with age-related macular degenerationRetina200525444344515933590
- MathewRSivaprasadSEnvironmental Amsler test as a monitoring tool for retreatment with ranibizumab for neovascular age-related macular degenerationEye (Lond)201226338939322173073
- SchuchardRAValidity and interpretation of Amsler grid reportsArch Ophthalmol199311167767808512478
- LoewensteinAMalachRGoldsteinMReplacing the Amsler grid: a new method for monitoring patients with age-related macular degenerationOphthalmology2003110596697012750099
- FineAMElmanMJEbertJEPrestiaPAStarrJSFineSLEarliest symptoms caused by neovascular membranes in the maculaArch Ophthalmol198610445135142420316
- ZaidiFHCheong-LeenRGairEJThe Amsler chart is of doubtful value in retinal screening for early laser therapy of subretinal membranes. The West London SurveyEye (Lond)200418550350815131682
- YannuzziLAA modified Amsler grid. A self-assessment test for patients with macular diseaseOphthalmology19828921571596175935
- MutlukanERed dots visual field test with blue on yellow and blue on red macula test gridEye (Lond)2006204506508 author reply 8–915895026
- WallMSadunAAThreshold Amsler grid testing. Cross-polarizing lenses enhance yieldArch Ophthalmol198610445205233954654
- WolfeKASadunAAThreshold Amsler grid testing in diabetic retinopathyGraefes Arch Clin Exp Ophthalmol199122932192231869055
- FinkWSadunAAThree-dimensional computer-automated threshold Amsler grid testJ Biomed Opt20049114915314715067
- NazemiPPFinkWLimJISadunAAScotomas of age-related macular degeneration detected and characterized by means of a novel three-dimensional computer-automated visual field testRetina200525444645315933591
- AlmonyAGargSPetersRKThreshold Amsler grid as a screening tool for asymptomatic patients on hydroxychloroquine therapyBr J Ophthalmol200589556957415834087
- NazemiPPFinkWSadunAAFrancisBMincklerDEarly detection of glaucoma by means of a novel 3D computer-automated visual field testBr J Ophthalmol200791101331133617504855
- KimJKFahimiAFinkWNazemiPPNguyenDSadunAACharacterizing ethambutol-induced optic neuropathy with a 3D computer-automated threshold Amsler grid testClin Experiment Ophthalmol200836548448818925920
- JivrajkaRVKimJKFinkWSadunAASebagJQuantitative analysis of central visual field defects in macular edema using three-dimensional computer-automated threshold Amsler grid testingGraefes Arch Clin Exp Ophthalmol2009247216517018958487
- RobisonCDJivrajkaRVBababeygySRFinkWSadunAASebagJDistinguishing wet from dry age-related macular degeneration using three-dimensional computer-automated threshold Amsler grid testingBr J Ophthalmol201195101419142321270434
- WestheimerGThe spatial sense of the eye. Proctor lectureInvest Ophthalmol Vis Sci1979189893912478780
- EnochJMWilliamsRAEssockEABarricksMHyperacuity perimetry. Assessment of macular function through ocular opacitiesArch Ophthalmol19841028116411686466179
- LakshminarayananVAzizSEnochJMVariation of the hyperacuity gap function with ageOptom Vis Sci19926964234261641222
- GoldsteinMLoewensteinABarakAResults of a multicenter clinical trial to evaluate the preferential hyperacuity perimeter for detection of age-related macular degenerationRetina200525329630315805906
- AlsterYBresslerNMBresslerSBPreferential hyperacuity perimeter (PreView PHP) for detecting choroidal neovascularization studyOphthalmology2005112101758176516154198
- ChewEYClemonsTEBresslerSBRandomized trial of the ForeseeHome monitoring device for early detection of neovascular age-related macular degeneration. The HOme Monitoring of the Eye (HOME) study design – HOME Study report number 1Contemp Clin Trials201437229430024530651
- ChewEYClemonsTEBresslerSBRandomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the Eye (HOME) studyOphthalmology2014121253554424211172
- QuerquesGBerbouchaELevezielNPeceASouiedEHPreferential hyperacuity perimeter in assessing responsiveness to ranibizumab therapy for exudative age-related macular degenerationBr J Ophthalmol201195798699121183512
- QuerquesGQuerquesLRafaeliOCanoui-PoitrineFBandelloFSouiedEHPreferential hyperacuity perimeter as a functional tool for monitoring exudative age-related macular degeneration in patients treated by intravitreal ranibizumabInvest Ophthalmol Vis Sci20115297012701821885622
- WilkinsonFWilsonHRHabakCDetection and recognition of radial frequency patternsVision Res19983822355535689893789
- WangYZWilsonELockeKGEdwardsAOShape discrimination in age-related macular degenerationInvest Ophthalmol Vis Sci20024362055206212037018
- WangYZHeYGMitzelGZhangSBartlettMHandheld shape discrimination hyperacuity test on a mobile device for remote monitoring of visual function in maculopathyInvest Ophthalmol Vis Sci20135485497550523860761
- KaiserPKWangYZHeYGWeisbergerAWolfSSmithCHFeasibility of a novel remote daily monitoring system for age-related macular degeneration using mobile handheld devices: results of a pilot studyRetina20133391863187023609122
- TrevinoRKynnMGMacular function surveillance revisitedOptometry200879739740318577497
- TrevinoRRecent progress in macular function self-assessmentOphthalmic Physiol Opt200828318319218426417
- Trauzettel-KlosinskiSBiermannPHahnGWeismannMAssessment of parafoveal function in maculopathy: a comparison between the macular mapping test and kinetic manual perimetryGraefes Arch Clin Exp Ophthalmol20032411298899514618339
- BartlettHDaviesLNEperjesiFThe macular mapping test: a reliability studyBMC Ophthalmol200551816092954
- AulhornEKöstGWhite noise field campimetry. A new form of perimetric examinationKlin Monbl Augenheilkd198819242842883404938
- SchieferUSkalejMKolbMLesion location influences perception of homonymous scotomata during flickering random dot pattern stimulationVision Res1998389130313129666998
- FreemanWREl-BradeyMPlummerDJScanning laser entoptic perimetry for the detection of age-related macular degenerationArch Ophthalmol2004122111647165115534125
- HuangDSwansonEALinCPOptical coherence tomographyScience19912545035117811811957169
- KeanePASaddaSRRetinal imaging in the twenty-first century: state of the art and future directionsOphthalmology2014121122489250025282252
- KeanePAPatelPJLiakopoulosSHeussenFMSaddaSRTufailAEvaluation of age-related macular degeneration with optical coherence tomographySurv Ophthalmol201257538941422898648
- DoDVGowerEWCassardSDDetection of new-onset choroidal neovascularization using optical coherence tomography: the AMD DOC studyOphthalmology2012119477177822297028
- KeanePABhattiRABrubakerJWLiakopoulosSSaddaSRWalshACComparison of clinically relevant findings from high-speed Fourier-domain and conventional time-domain optical coherence tomographyAm J Ophthalmol20091482242248.e119427620
- LuCDKrausMFPotsaidBHandheld ultrahigh speed swept source optical coherence tomography instrument using a MEMS scanning mirrorBiomed Opt Express20135129331124466495
- GrulkowskiILiuJJPotsaidBRetinal, anterior segment and full eye imaging using ultrahigh speed swept source OCT with vertical-cavity surface emitting lasersBiomed Opt Express20123112733275123162712
- GrulkowskiILiuJJZhangJYReproducibility of a long-range swept-source optical coherence tomography ocular biometry system and comparison with clinical biometersOphthalmology2013120112184219023755873
- WalshACBinocular optical coherence tomographyOphthalmic Surg Lasers Imaging2011424S95S105
- PuliafitoCAOCT angiography: the next era of OCT technology emergesOphthalmic Surg Lasers Imaging Retina201445536025291781
- SchwartzDMFinglerJKimDYPhase-variance optical coherence tomography: a technique for noninvasive angiographyOphthalmology2014121118018724156929
- JiaYBaileySTWilsonDJQuantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degenerationOphthalmology201412171435144424679442